Distributed by Mapi Research Trust
Distributed by Mapi Research Trust
Developed in 2008
Mapi
All
PRO
Arnould B, Gauchoux R, Meunier J, Gilet H, Regnault A. Validation of ACCEPT, a new generic measure to assess how patients with chronic diseases balance between the advantages and disadvantages of following the recommended treatment regimen in real-life. ISPOR 16th Annual European Congress, Dublin, Ireland, November 2013
Marant C, Longin J, Gauchoux R, Arnould B, Spizak C, Marrel A, Patrick DL, Van Ganse E. Long-term treatment acceptance: what is it, and how can it be assessed? Patient. 2012;5(4):239-49 (PubMed Abstract)
Chretin S, Viala-Danten M, Van Ganse E, Patrick D, Arnould B, Longin J. The missing piece between treatment experience and intention to persist: testing the internal consistency reliability and predictive validity of acceptability. ISPOR 13th Annual European Congress, Prague, Czech Republic, November 2010
Marant C, Longin J, Spizak C, Patrick D, Saussier C, Arnould B, Van Ganse E. What does acceptability mean for patients and how should it be measured? Qualitative steps for the development of a new measurement instrument for pharmacies: the “ACCEPT©” questionnaire. ISPOR 11th Annual European Congress, Athens, Greece, November 2008
Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66
All requests have to be submitted through our online request management:
| ROYALTY FEES* | Commercial users | Cost per study | 1 500 € |
| Cost per language | 500 € | ||
| Funded academic research | Cost per study | Free | |
| Cost per language | Free | ||
| Not funded academic users | Cost per study | Free | |
| Cost per language | Free |
| DISTRIBUTION FEES* | Commercial users | Cost per study | 700 € |
| Cost per language | 300 € | ||
| Funded academic research | Cost per study | 300 € | |
| Cost per language | 50 € | ||
| Not funded academic users | Cost per study | Free | |
| Cost per language | Free |
* Excluding VAT
Commercial users: Industry, CRO, any for-profit companies
Funded Academic research: Projects receiving funding from commerce, government, EU or registered charity. Funded academic research– sponsored by industry fits the “commercial users” category.
Not funded academic users, individual medical practice: Projects are not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds
Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.
The translations listed may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.
The author has selected Mapi as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.
For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).
If you wish to translate the questionnaire:
Subscribe to PROQOLID™
And get access to advanced descriptions of Clinical Outcome Assessments (COAs)!
SubscribePurchase a limited access to this COA instrument page
This will allow you to view this specific COA page during one active session of 12 hours max starting at your first attempt. Note that if your session is inactive for four hours, your access will be closed.